Blue Sail Medical has completed the acquisition of NVT: the advisor

Blue Sail Medical, a Chinese medical device company, listed at Shenzhen Stock Exchange, has entered into a share purchase agreement to acquire NVT on 20 September 2019. NVT develops, manufactures and markets medical devices for interventional cardiology and cardiac surgery for minimally invasive treatment of valvular heart disease. After receipt of the required regulatory permits and completion of the agreed carve-out the transaction was closed on 8 June 2020.

The team

Walder Wyss acted as lead counsel to the private sellers. The team has been co-led by partner Urs P. Gnos (corporate/m&a – pictured right) and managing associate Samuel Lieberherr (corporate/m&a – pictured left) and further included partner Markus Vischer (corporate/m&a), associate Claudia Weber (corporate/m&a), counsel Janine Corti (tax), managing associate Simone Wetzstein (employment) and associate Lara Alec (corporate/m&a).

Blue Sail Medical has completed the acquisition of NVT: the advisor


Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2023 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram